Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC

Clinical trial NCT06709274 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06709274
Sponsor: Guangdong Association of Clinical Trials
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2024-11-01
Primary completion: 2029-01-01
Enrollment: 342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.